StabilZyme™ Protein-Free Stabilizer

Cat. No.: S573236

Übersicht

Enzyme:Horseradish peroxidase

Spezifikationen

Product Name

StabilZyme™ Protein-Free Stabilizer

Molekültyp

Bioreagenzien/Puffer

Lagerung und Versand

Storage

Store at 2-8°C

Verschickt in

Wet ice

Application Protocols

No item-specific, validated protocols are provided in the Product Data. The following are general, literature-based examples to guide use; adjust to your assay requirements and consult the CoA/Spec Sheet.

• Antibody conjugate dilution (ELISA, general):
  1. Equilibrate stabilizer to room temperature. 2) Prepare serial dilutions of HRP- or AP-conjugated antibody in stabilizer. 3) Incubate per assay design. 4) Store any remaining working solution at 2–8°C for short periods; avoid contamination.
• Standard/Control preparation: Reconstitute lyophilized proteins in stabilizer instead of plain buffer to reduce adsorption losses at low concentration; mix gently by inversion.
• Plate preconditioning: Add 200–300 µL/well of stabilizer to assay plate, incubate 5–15 min, and discard before adding reagents to reduce early adsorption (verify that this does not alter blocking strategy).
• Short-term storage of proteins: Aliquot into low-binding tubes containing stabilizer; fill to minimize headspace; store 2–8°C. Evaluate stability over intended timeframe.

Critical notes:

• Check whether preservatives are present before using with azide-sensitive enzymes or live cells.
• Verify compatibility with detection chemistry (TMB, pNPP, chemiluminescent substrates) and adjust dilution factors as needed.

Biological Roles

This product is not a biological macromolecule but functions to preserve the biological activity of proteins in vitro. No endogenous biological role is implied.

• Mode of action (general/literature): Protein-free stabilizers often employ osmolytes, polymers, and buffering ions that help maintain protein folding thermodynamics, reduce interfacial denaturation at air–liquid and solid–liquid boundaries, and limit aggregation by moderating weak interactions.
• Impact on assays (general):
  • Maintains antibody affinity/avidity during incubation and storage.
  • Preserves enzymatic reporters (e.g., HRP, AP) by buffering microenvironment and limiting adventitious adsorption to plastics.
  • Helps maintain consistent signal across plates or strips by reducing edge and time effects linked to protein loss.
• Considerations:
  • Verify compatibility with specific enzymes, cofactors, and detection chemistries; some stabilizers can modulate kinetics at high concentrations.
  • Confirm that the absence of protein blockers is suitable; in some cases, a dedicated blocker (protein or synthetic) may still be required.

No clinical/therapeutic implications are claimed. Use is strictly for research workflows where maintenance of protein function and assay reproducibility is necessary.

Buffer Applications

Highly applicable. StabilZyme Protein-Free Stabilizer is used as a ready-to-use or dilutable component in immunoassay and protein-handling buffers.

• Typical roles (general):
  • Conjugate diluent: Maintain HRP/AP-antibody conjugate stability during assay setup and short-term storage.
  • Specimen/reagent stabilizer: Reduce loss of antigen/antibody to plastics in low-protein matrices.
  • Plate handling: Pre-rinse or precondition microplates and pipette tips to limit adsorption at low analyte levels.
• Integration into workflows (general guidance):
  • For ELISA: Use as the diluent for standards, controls, and conjugates; match matrix across the standard curve and samples to minimize matrix effects.
  • For lateral flow: Use as part of the conjugate pad reconstitution buffer and/or running buffer if compatible with membrane wetting.
  • For storage at 2–8°C: Aliquot proteins into low-binding tubes prefilled with stabilizer to minimize headspace and interfacial stress.
• Compatibility checks:
  • Confirm with CoA whether any preservatives are present before combining with azide-sensitive enzymes (e.g., HRP) or living cells.
  • Verify ionic strength and surfactant content for applications like SPR, BLI, or MS that can be sensitive to additives.

Item-specific pH, ionic strength, and composition: Not specified for this item; refer to CoA/Spec Sheet.

Green Alternatives

For laboratory buffers, “green” considerations focus on aqueous, low-toxicity components, minimal biocide burden, and waste reduction.

• Current product context: An aqueous, protein-free stabilizer aligns with green chemistry principles by avoiding animal-derived proteins and minimizing reliance on organic solvents (general observation). Specific preservative content is Not specified for this item; refer to CoA/Spec Sheet.
• Greener practice tips (general):
  • Prepare only the volumes needed; maintain cold-chain to reduce waste from microbial compromise.
  • If a preservative-free version is available or required, handle under aseptic conditions and use promptly to avoid adding hazardous biocides.
  • Prefer phosphate or Good’s buffers with low environmental impact when making dilutions.
  • Consolidate shipments and use reusable ice packs to reduce cold-chain footprint.
• Comparison considerations (general):
  • Versus BSA-containing blockers: protein-free reduces animal-derived inputs and potential biohazard waste.
  • Versus solvent-based stabilizers: aqueous systems lower VOC emissions and flammability risks.

Disposal: Treat spent buffer as non-hazardous aqueous laboratory waste unless assay additives (e.g., substrates, metals, azides) are present—follow institutional and local regulations and the SDS for the specific lot.

Pharmaceutical Uses

This product is designated for research use only. It is not supplied with GMP/clinical certifications and is not intended for diagnostic or therapeutic use.

In a research and development context (general):

• May serve as a development surrogate for formulation screening of protein biologics, helping to identify classes of excipients that mitigate aggregation and adsorption, prior to transferring learnings into pharmacopeial, GMP-grade excipients.
• Useful in analytics (ELISA, binding assays) supporting preclinical development by improving assay precision and reagent stability.
• Can aid reference standard handling, where low-concentration proteins are aliquoted and stored short-term at 2–8°C to preserve integrity during analytical runs.

Regulatory considerations:

• For any application near regulated workflows, replace with GMP/IVD-grade materials and document full composition and quality attributes.
• Consult your QA/QC team and the SDS/CoA for allowable use. Do not incorporate into clinical products or in-process materials without formal qualification.

No claims are made regarding compliance with USP/EP/JP monographs or pharmacopeial excipient status for this product. Composition, pH, and preservative content are Not specified for this item; refer to CoA/Spec Sheet.

Physical Properties

As a proprietary aqueous solution, fixed compound-level properties are not applicable. Where helpful, we note general expectations for this class of materials and clearly distinguish them from item-specific specifications.

• Physical state/appearance: Not specified for this item; refer to CoA/Spec Sheet.
• pH: Not specified for this item; refer to CoA/Spec Sheet. (Protein-stabilizing buffers are often buffered near neutral pH in the literature.)
• Density: Not specified for this item; refer to CoA/Spec Sheet.
• Osmolality/ionic strength: Not specified for this item; refer to CoA/Spec Sheet.
• Solubility: Miscible with water (general for aqueous buffers). Compatibility with organic solvents should be validated case-by-case.
• Refractive index/conductivity: Not specified for this item; refer to CoA/Spec Sheet.
• Boiling point / melting point / vapor pressure: Not meaningful for an aqueous laboratory buffer; dominated by water behavior (literature/general).
• Viscosity: Not specified for this item; refer to CoA/Spec Sheet. (Protein-stabilizing formulations may have slightly elevated viscosity when polymeric excipients are used—literature/general.)

Notes for use (general):

• Filterability through 0.22 µm or 0.45 µm membranes is typical for aqueous assay buffers; confirm with the specific lot documentation.
• If downstream optical measurements are sensitive, check UV–Vis background of the lot versus assay wavelengths (general guidance).

Quality and Grades

• Grade/Purity (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
• Intended use: Research use only (as stated). Not for diagnostic or therapeutic applications.
• Typical quality attributes for protein-stabilizing buffers (literature/general):
  • Low bioburden and particulate content; often 0.2 µm filtered.
  • Controlled pH and conductivity with documented lot-to-lot consistency.
  • Low background absorbance/fluorescence for optical assays.
  • Minimal interfering ions/additives that could chelate metals or suppress enzyme activity, unless explicitly designed to do so.
• Stabilizer implications (general): “Protein-free” indicates no added albumin or other proteins—useful to reduce non-specific binding, eliminate animal-derived components, and preserve native assay backgrounds. Such formulations commonly protect against:
  • Surface adsorption of target proteins/antibodies to plastics and glass.
  • Aggregation/denaturation during storage and freeze–thaw.
  • Activity loss for enzymes or conjugates by microenvironment stabilization.
• Documentation: Request the Certificate of Analysis (CoA) and Specification Sheet for lot-specific pH, filtration, sterility/bioburden status, and any preservatives.

If regulatory or diagnostic (IVD/GMP) use is planned, verify suitability and certifications; this catalog item is designated for research use only.

Reaction and Applications

Primary utility is in biomolecular stabilization rather than chemical synthesis. Key application domains (literature/general):

• Immunoassays: ELISA, CLIA, ECL, lateral flow—as a conjugate diluent or sample/reagent stabilizer to maintain antibody/antigen binding competence and enzyme conjugate activity during assay setup and storage.
• Bioconjugates: Stabilization of HRP-, AP-, fluorophore-, or nanoparticle-conjugated proteins by reducing aggregation and non-specific adsorption to plastics.
• Protein storage/handling: Short-to-intermediate term storage at 2–8°C for low-concentration proteins, minimizing losses on tube walls and during pipetting.
• Adsorption control: Reduces surface binding to polypropylene and polystyrene, important for dilute protein solutions (sub-µg/mL).
• Background control: Protein-free composition helps avoid added protein signals in downstream detection and minimizes species cross-reactivity.

Practical tips (general):

• Use clean, low-binding plastics and pre-equilibrate vessels with stabilizer when handling sub-µg/mL proteins.
• Mix gently to avoid foaming if surfactants are present in a given formulation (check CoA).
• Validate that the stabilizer does not interfere with enzymatic reporters or secondary detection chemistries at working concentrations.
• If long-term storage is required, consider aliquoting and refrigeration; evaluate freezing only if supported by the specific formulation documentation.

Reaction Conditions

Conventional chemical reaction conditions are not applicable. The relevant “conditions” concern handling and storage of proteins/bioconjugates in vitro.

General guidance (literature/general):

• Temperature: Use and store at 2–8°C as specified for the item. Bring to room temperature before use to minimize condensation and pH drift; avoid repeated temperature cycling.
• Contact time: Compatible with prolonged contact typical of ELISA incubations (tens of minutes to hours), but verify that extended storage of sensitive conjugates meets your acceptance criteria.
• Surfaces: Employ low-binding plastics or precondition standard plastics with stabilizer. Minimize air–liquid interfaces (fill tubes adequately, avoid vigorous vortexing).
• Additives: If adding salts, cofactors, or substrates, confirm that final concentrations do not destabilize proteins or interfere with assay readout.
• Filtration/sterility: If sterility is required, confirm filterability and bacterial endotoxin/bioburden limits from the CoA; do not assume sterile status unless stated.

Expected performance metrics such as half-life extension or activity retention are system- and protein-dependent; establish these empirically under your assay conditions.

Safety and Handling

• GHS classification, signal word, pictograms, H-statements: Not specified for this item; refer to the product SDS for authoritative hazard information.
• General hazard profile (literature/general): Protein-free assay stabilizers are commonly low hazard aqueous solutions; however, some formulations may contain preservatives or surfactants that warrant standard laboratory precautions.
• Recommended PPE: Laboratory coat, safety glasses, and disposable nitrile gloves. Avoid inhalation of aerosols and contact with eyes/skin. Wash hands after handling.
• Storage conditions (item-specific): Store at 2–8°C. Maintain container tightly closed. Do not use if signs of contamination, precipitation, or color change are observed unless validated.
• Shipping (item-specific): Shipped on wet ice to maintain recommended temperature during transit.
• Incompatibilities (general): Avoid mixing with strong oxidizers or reducers unless compatibility is documented. If the formulation contains surfactants or chelators, be mindful of interactions with hydrophobic plastics or trace metals (general guidance).
• First aid (general):
  • Eye contact: Rinse cautiously with water for several minutes; seek medical advice if irritation persists.
  • Skin contact: Wash with soap and water; remove contaminated clothing.
  • Ingestion: Rinse mouth; seek medical advice.
  • Inhalation of mists: Move to fresh air; seek medical advice if symptoms occur.
• Spill/cleanup (general): Absorb with inert material, collect, and rinse area with water. Dispose according to institutional and local regulations.

Always consult the SDS for lot-specific safety data and regulatory guidance.

Solvent Selection

This product is an aqueous stabilizer intended to be used as supplied or diluted with water or buffer. Organic solvent selection is generally not applicable.

• Polarity/miscibility: Water-based; fully miscible with water and common biological buffers (PBS, TBS) in general. Compatibility with high levels of organic cosolvents (e.g., >10–20% methanol, ethanol, DMSO) should be validated experimentally as stabilizer performance can change (literature/general).
• Use scenarios (general):
  • Directly as a diluent for antibodies, antigens, or enzyme conjugates to minimize adsorption and activity loss.
  • As a storage buffer component for proteins between 2–8°C.
  • As a blocking/dilution matrix in immunoassays where protein blockers are undesirable.
• Comparison guidance (general):
  • Protein-free stabilizer vs BSA-containing buffer: protein-free minimizes background and avoids animal-derived components; BSA may offer stronger blocking but can introduce cross-reactivity.
  • Protein-free stabilizer vs simple PBS/TBS: offers enhanced stabilization against adsorption/aggregation, especially at low protein concentrations.

Recommendation: Use ultrapure water for any dilutions. Confirm compatibility with assay readouts (e.g., HRP/TMB, AP/pNPP) and avoid introducing solvents or salts that could alter kinetics unless validated.

Storage and Reconstitution

• Storage conditions (item-specific): Store at 2–8°C. Maintain container tightly closed to prevent contamination and evaporation.
• Shipping (item-specific): Shipped on wet ice to preserve the cold chain.
• Reconstitution: Not applicable—product is supplied as a ready-to-use aqueous solution unless otherwise stated. If concentrates are provided for a given lot, dilution instructions will be on the CoA/Spec Sheet (Not specified for this item).
• Handling:
  • Do not freeze unless the specification explicitly permits; freezing can cause phase separation or excipient precipitation in some stabilizer formulations.
  • Mix by gentle inversion; avoid vigorous shaking that can introduce foam and air–liquid interfacial stress.
  • Use sterile/clean techniques to avoid microbial contamination. If sterility is required, confirm status on the CoA; consider aseptic aliquoting.
• In-use stability: Not specified for this item; refer to CoA/Spec Sheet. Establish laboratory-specific open-vial and working-solution hold times under your conditions.
• Container compatibility: Use compatible plastics (PP, PE) or glass; verify that low-binding labware is suitable for your assay.

Always consult the product CoA and SDS for lot-specific details on composition, pH, preservatives, and any special handling instructions.

Structure and Identity

StabilZyme Protein-Free Stabilizer is a proprietary, aqueous, protein-free stabilization solution formulated for in vitro research workflows (e.g., immunoassays). As a formulated mixture, it does not have a single chemical identity.

• Item type: Proprietary aqueous stabilizer/buffer, protein-free
• Molecular formula: Not applicable to mixtures; Not specified for this item; refer to CoA/Spec Sheet.
• Molecular weight: Not applicable to mixtures; Not specified for this item; refer to CoA/Spec Sheet.
• SMILES / InChI / InChIKey: Not applicable to mixtures; not assigned.
• Structural features (general):
  • Likely contains a buffered saline base with proprietary stabilizing excipients to minimize protein unfolding and surface adsorption (literature/general).
  • No added protein (albumin-free), reducing background and species cross-reactivity in immunoassays (general).
• Formulation class description (general): protein-free stabilizers typically employ combinations of buffering ions, osmolytes, polymers, and/or surfactants to reduce denaturation, aggregation, and non‑specific adsorption during storage and assay handling (literature/general).

Because this product is a formulation, a single 2D structure depiction is not applicable. For composition specifics, consult the manufacturer’s technical data sheet and CoA.

Synthetic Utility

Not typically applicable. StabilZyme Protein-Free Stabilizer is a formulated aqueous mixture intended for biomolecule stabilization, not a reagent for chemical synthesis or transformations.

For laboratories integrating chemistry and biology (general guidance):

• Use this stabilizer downstream of synthetic or bioconjugation steps to maintain protein integrity during purification, storage, and analytical assays.
• Avoid assuming compatibility with metal-catalyzed reactions, organic solvents, or coupling reagents—validate separately if any carryover into chemical steps is anticipated.

If you require buffers tailored to specific synthetic workflows (e.g., peptide coupling, click chemistry), select dedicated reaction-compatible media with known composition and purity grades.

Target Specificity

Not applicable. This product is a stabilizer buffer, not an antibody or affinity reagent. No antigen/epitope specificity, clone, isotype, or species reactivity applies. For target-specific antibodies, consult the corresponding product pages.

Häufig gestellte Fragen

How should this product be stored?

Store at 2–8 °C. Refrigerated storage is required to maintain the specified shelf life.

How is this product shipped?

This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.